Viewing Study NCT03076957


Ignite Creation Date: 2025-12-24 @ 7:03 PM
Ignite Modification Date: 2026-01-12 @ 8:55 AM
Study NCT ID: NCT03076957
Status: UNKNOWN
Last Update Posted: 2017-03-10
First Post: 2016-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj.
Sponsor: Chong Kun Dang Pharmaceutical
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module